Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 929 | 917 | 941 | 1307 | 1376 | 2575 |
Fund Return | -7.11% | -8.29% | -5.87% | 9.33% | 6.6% | 9.92% |
Place in category | 118 | 238 | 104 | 69 | 27 | 22 |
% in Category | 39 | 65 | 38 | 17 | 10 | 9 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MG Japan Fund Sterling I Acc | 3.53B | 9.72 | 8.05 | 10.20 | ||
MG Japan Fund Sterling I Inc | 3.53B | 9.73 | 8.04 | 10.21 | ||
MG Japan Fund Sterling R Acc | 3.53B | 9.51 | 7.78 | 9.93 | ||
MG Japan Fund Sterling R Inc | 3.53B | 9.52 | 7.77 | 9.92 | ||
MG Managed Growth Fund Sterling I A | 1.01B | 10.78 | 7.98 | 9.21 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPEurope Strategic Value Fund A dig | 1.54B | -0.32 | 9.30 | 4.63 | ||
European Value Fund D2g | 147.88M | 15.30 | 10.96 | 7.11 | ||
Brandes European Value Fund A GBP A | 691.56M | -0.50 | 10.30 | 6.24 | ||
Brandes European Value Fund I GBP A | 691.56M | -0.30 | 11.21 | 6.72 | ||
Funds European Equity Class Zg | 51.09M | 7.34 | 7.20 | 5.99 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 3.82 | 100.98 | +0.02% | |
Roche Holding Participation | CH0012032048 | 3.69 | 273.30 | +0.63% | |
TotalEnergies SE | FR0000120271 | 3.39 | 59.66 | -0.20% | |
BP | GB0007980591 | 3.24 | 399.60 | -0.10% | |
Securitas B | SE0000163594 | 2.45 | 131.10 | +0.58% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review